A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema
Status:
Unknown status
Trial end date:
2020-09-15
Target enrollment:
Participant gender:
Summary
This phase I trial will assess primarily the safety and secondarily anti-inflammatory effect
of Episcleral Dexamethasone in patients suffering from refractory diabetic macular edema.